ANI Pharmaceuticals Receives FDA Approval For The Abbreviated New Drug Application For Estradiol Gel, 0.1%, Generic Version Of Divigel For Severe Vasomotor Symptoms (Hot Flashes, Night Sweats) Due To Menopause
Portfolio Pulse from Benzinga Newsdesk
ANI Pharmaceuticals has received FDA approval for the Abbreviated New Drug Application for Estradiol Gel, 0.1%, a generic version of Divigel. This drug is used for severe vasomotor symptoms (hot flashes, night sweats) due to menopause.
August 28, 2023 | 10:52 am
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
ANI Pharmaceuticals' stock may see a positive impact due to the FDA approval of their generic version of Divigel.
FDA approval for a new drug is a significant positive event for pharmaceutical companies. This approval allows ANI Pharmaceuticals to market and sell their generic version of Divigel, potentially increasing their revenues and profitability, which could positively impact their stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100